Singco, Nash Caesar T.

HRN: 24-68-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
CEFUROXIME 1.5GM (VIAL)
03/13/2024
03/20/2024
IV
1.5g
Q8
Fracture Close Complete 4th And 5th Digit MTC Right Hand
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bone & JointProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: